STROKE JOURNAL BY DR. JONATHAN BRISMAN
AND DR. JOHN PILE-SPELLMAN

Dr Jonathan Brisman and Dr John Pile-Spellman have produced a journal representing six articles in peer-reviewed journals and textbook chapters that have been published by the NSPC neurovascular team in the last few years. Both Dr. Brisman and Dr. Pile-Spellman have continued in the strong academic tradition of research and scientific publication because they believe that the complexity of cerebrovascular disease demands it. In order to continue to advance the field, it is their belief, these illnesses must be studied in depth, the data recorded, analyzed, reviewed and put down on paper.
Read Journal

OPEN CLINICAL TRIALS

Phase II Pilot Trial of Hyperbaric Hyperoxygenation in Conjunction with Radiotherapy and Temozolomide in Adults with Newly Diagnosed Glioblastomas (Jan 2010)
The Long Island Brain Tumor Center at Neurological Surgery, PC and Winthrop University Hospital are conducting a clinical trial using hyperbaric therapy in conjunction with radiation and chemotherapy in the treatment of newly diagnosed glioblastomas (malignant brain tumors).  If you or someone in your family has recently been diagnosed with a glioblastoma, call one of our experienced Patient Care Coordinators now at 516-478-0010 or 631-864-3900 for an immediate consultation.  You’ll never need to wait for an appointment.  At The Long Island Brain Tumor Center at Neurological Surgery, PC, we offer hope, compassion and new treatment options close to home, and we’re just a phone call away.

http://clinicaltrials.gov/ct2/show/NCT00936052?term=glioblastoma+and+hyperbaric&rank=1

Phase III, Double-Blind, Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide plus Bevacizumab versus Conventional Concurrent Chemoradiation and Adjuvent Temozolomide in Patients with Newly Diagnosed Glioblastoma

• Protocol: RTOG 0825
• SNCH Co-Investigators: J. Paul Duic, M.D., and Jai Grewal, M.D.
• Sponsor: National Cancer Institute/Radiation Therapy Oncology Group
• Objective: To determine if the addition of bevacizumab to radiation therapy and
  temozolomide will improve survival for persons with cancerous brain tumor, called
  glioblastoma.
• Study Criteria: Patients must have confirmed glioblastoma, accomplished by tumor
  tissue laboratory evaluation.

For more information or to see if one qualifies for this study, call 516-478-0010 or 631-864-3900.

View PDF on Bevacizumab for Patients with GLIOBLASTOMA

CLOSED CLINICAL TRIALS

CLINICAL STUDIES (June 2008)
Dr Jai Grewal and Dr Paul Duic will be conducting clinical studies for patients with the following criteria:
Patients must have confirmed non-small cell lung cancer and 1-3 brain metastases. 
(This study is now closed Dec 2009)

Clinical Studies (June 2008)
Dr Jai Grewal and Dr Paul Duic will be conducting clinical studies for patients with the following criteria:
Patients must have a confirmed glioblastoma, accomplished by tumor tissue laboratory evaluation

CASE STUDIES

Brain Tumor Program- Case 3 (Aug 2009)

Stereotactic Radiosurgery - Case 1

Stereotactic Radiosurgery- Case 2